Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
Vanessa F Moreira FerreiraYanqing LiuBrian C HealyJames M StankiewiczPublished in: Multiple sclerosis journal - experimental, translational and clinical (2021)
Dimethyl fumarate showed a trend towards reduction in T25FW but no evidence of clinically significant impact on EDSS. The small sample precluded definitive determination.